PD-L1 expression and association with patient outcome in a large pediatric cohort

Federica Saletta; Ricardo E. Vilain; Aysen Yuksel; Amit Gupta; Sumanth Nagabushan; Richard A Scolyer; Casey L. Daniel; Jenny Byrne; Geoffrey McCowage

doi:10.1016/s0959-8049(16)32867-2

Related publications

Article2017

Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in Neuroblastoma

Federica Saletta, Ricardo E. Vilain, Aditya Gupta, Sumanth Nagabushan, Aysen Yuksel, Daniel Catchpoole, Richard A Scolyer, Jennifer A. Byrne, Geoffrey McCowage

Article2019

Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer

Angela Hong, Peter M. Ferguson, Tristan Dodds, D. Brian Jones, Mengbo Li, Jean Yang, Richard A Scolyer

Article2017

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors

Hojabr Kakavand, Robert V. Rawson, Gulietta M. Pupo, Jean Yang, Alexander M. Menzies, Matteo S. Carlino, Richard Kefford, Julie R. Howle, Robyn P.M. Saw, John F. Thompson, James S. Wilmott, Georgina V. Long, Richard A Scolyer, Helen Rizos

Article2015

Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases

Hojabr Kakavand, Ricardo E. Vilain, James S. Wilmott, Hazel Burke, Jennifer H. Yearley, John F. Thompson, Peter Hersey, Georgina V. Long, Richard A Scolyer

Article2015

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma

Wendy A. Cooper, Trần Nam Thắng, Ricardo E. Vilain, Jason Madore, Christina Selinger, Maija R.J. Kohonen‐Corish, Po Yee Yip, Bing Yu, Sandra A. O’Toole, Brian C. McCaughan, Jennifer H. Yearley, Lisa G. Horvath, Steven Kao, Michael Boyer, Richard A Scolyer